Smiths Medical ASD Inc. DuraLife Autoclavable Silicone Extension Tube, REF 60-1502 (UltraSet Product Code 66-2509); Non-Ported Double Swivel Elbow for use with breathing circuits Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
DuraLife Autoclavable Silicone Extension Tube, REF 60-1502 (UltraSet Product Code 66-2509); Non-Ported Double Swivel Elbow for use with breathing circuits
Brand
Smiths Medical ASD Inc.
Lot Codes / Batch Numbers
3569291, 3802463, 3974741, 4093611, 4219069, 4340640, 3582651, 3832622, 4001787, 4108514, 4242510, 4340642, 3609721, 3871182, 4011956, 4116120, 4254340, 3609743, 3891814, 4032896, 4122394, 4264898, 3693349, 3914797, 4041943, 4151071, 4279831, 3723464, 3927549, 4063256, 4167796, 4290272, 3761125, 3952707, 4090324, 4182390, 4340638
Products Sold
3569291, 3802463, 3974741, 4093611, 4219069, 4340640, 3582651, 3832622, 4001787, 4108514, 4242510, 4340642, 3609721, 3871182, 4011956, 4116120, 4254340, 3609743, 3891814, 4032896, 4122394, 4264898, 3693349, 3914797, 4041943, 4151071, 4279831, 3723464, 3927549, 4063256, 4167796, 4290272, 3761125, 3952707, 4090324, 4182390, 4340638
Smiths Medical ASD Inc. is recalling DuraLife Autoclavable Silicone Extension Tube, REF 60-1502 (UltraSet Product Code 66-2509); Non-Port due to DuraLife devices instructions for cleaning and sterilization have been determined to be inadequate. Specifically, for the DuraLife product, the IFU do. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
DuraLife devices instructions for cleaning and sterilization have been determined to be inadequate. Specifically, for the DuraLife product, the IFU does not provide the cleaning method, duration of autoclave cycle or specify the number of cycles the product can be reused on a single patient.
Recommended Action
Per FDA guidance
Smiths Medical issued an URGENT MEDICAL DEVICE RECALL notice on 04/05/2023 by mail (traceable method). The notice explained the issue, potential risk, and request the following actions be taken: "Please discontinue the use and distribution of the affected product immediately. Check your inventory and quarantine all affected product at your facility. If you have expired product, do not use. 2) Inform potential users of the product in your organization of this notification and complete the attached response form. Return the completed response form to the fax number or e-mail address on the form, even if you do not have the affected product. 3) Return affected product using the return label provided with this letter. Contact Sedgwick at 1-844-861-6220 (MF, 8am-5pm ET) if you have not received a return label or require additional labels for returning the affected product." "If you have distributed the product further, immediately notify your accounts that received the product identified in the Affected Product / Table 1 sections of this notification and ask them to contact Sedgwick at 1-844-861-6220 (M-F, 8am-5pm ET) to obtain a response form."
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026